Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PURITAN MEDICAL

New Process to Create Artificial Cell Membranes Developed

By BiotechDaily International staff writers
Posted on 17 Oct 2013
Image: Quantitative deposition of lipid monolayers yielded vesicles with fluorescence variance in agreement with model predictions (Photo courtesy of Scripps Research Institute, via Nature Chemistry).
Image: Quantitative deposition of lipid monolayers yielded vesicles with fluorescence variance in agreement with model predictions (Photo courtesy of Scripps Research Institute, via Nature Chemistry).
Scientists have developed a highly programmable and controlled platform for preparing and experimentally studying synthetic cell-like membrane-enclosed structures.

Understanding the myriad biochemical roles of membranes surrounding cells and inside them requires the ability to prepare realistic synthetic versions of these complex multilayered structures, a long-standing challenge. In a study published in the journal Nature Chemistry, online September 29, 2013, scientists at The Scripps Research Institute (TSRI; Jupiter, FL, USA) describe an innovative method they have developed for studying cell-like membrane-enclosed vesicles—layer-by-layer phospholipid membrane assembly on microfluidic droplets, a route to structures with defined compositional asymmetry and lamellarity.

Starting with a technique commonly used to deposit molecules on a solid surface, Langmuir-Blodgett deposition, the scientists repurposed the approach to work on liquid objects. They engineered a microfluidic device containing an immobilized array of microscopic cups, each trapping a single droplet of water bathed in oil and lipids. The arrayed trapped droplets are then ready to serve as a foundation for building up a series of lipid layers like coats of paint. “Layer-by-layer membrane assembly allows us to create synthetic cells with membranes of arbitrary complexity at the molecular and supramolecular scale,” said TSRI Assistant Professor Brian Paegel, who authored the study with Research Associate Sandro Matosevic; “We can now control the molecular composition of the inner and outer layers of a bilayer membrane, and even assemble multilayered membranes that resemble the envelope of the cell nucleus.”

The lipid-coated water droplets are first bathed in water. As the water/oil interface encounters the trapped droplets, a second lipid layer coats the droplets and transforms them into unilamellar vesicles. Bathing the vesicles in oil/lipid deposits a third lipid layer, which is followed by deposition of a final layer of lipids. The final product after these three phase exchanges is an immobilized array of double-bilayer vesicles.

“The computer-controlled microfluidic circuits we have constructed will allow us to assemble synthetic cells not only from biologically derived lipids, but from any amphiphile and to measure important chemical and physical parameters, such as permeability and stability,” said Prof. Paegel.

Related Links:
The Scripps Research Institute




Channels

Genomics/Proteomics

view channel
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).

Methods Developed to Generate Normal Stem Cells from Patients with Mitochondrial Defects

A recent paper described two methods for converting cells from patients with mitochondrial defects into normal pluripotent stem cells that could be induced to differentiate into several different types of tissues.... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.